Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) insider Timothy Rolph sold 509 shares of Akero Therapeutics stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $55.16, for a total transaction of $28,076.44. Following the completion of the transaction, the insider now directly owns 189,420 shares […]